H.C. Wainwright initiated coverage of Agios Pharmaceuticals (AGIO) with a Buy rating and $58 price target The firm views the company’s lead ...
Investment analysts at HC Wainwright issued their Q4 2025 EPS estimates for Prothena in a research note issued to investors on Friday, February 21st. HC Wainwright analyst A. Fein expects that the ...
HC Wainwright reiterated their buy rating on shares of SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) in a report ...
H.C. Wainwright analyst Mike Colonnese notes that Coinbase (COIN) announced that the Securities and Exchange Commission has agreed to dismiss ...
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced that Michael Klichinsky, PharmD, PhD, Co-founder ...
Highlights,Adjusted Q1 2025 EPS projections for Bausch + Lomb as analysts slightly reduce expectations.,Diverse analyst ...
We recently published a list of 12 Best Robinhood Stocks to Buy Under $20. In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results